After previewing its plans to open a marketplace to "redistribute" dormant handles last month, X has made the feature available to all Premium+ subscribers on the platform. The feature allows ...
Kite, an artificial intelligence (AI)-powered payments blockchain, rolled out its native token on Monday, generating significant trading volume on South Korean exchanges Upbit and Bithumb. The token ...
X is launching a marketplace for inactive handles that will allow Premium subscribers to request and purchase usernames. The marketplace will offer both free and paid options for requesting or ...
CHESTNUT HILL, Mass. — Cade Klubnik and the Clemson offense kept rolling in a 41-10 win at Boston College. The senior quarterback finished 22-of-30 passing for 280 yards, helping the Tigers out to a ...
Proposed regulations in China would mean the end of flush handles on car doors, with precious little time to roll out the changes. Car door handles seem innocuous. Tesla’s electronic, retractable ones ...
Some of the best relationships are beginning right on our doorsteps. Sometimes without us even knowing. We're talking about love at first sight, soul connection stuff. The type where the two can't ...
Earlier this week, Ars spent some time driving the new Nissan Leaf. We have to wait until Friday to tell you how that car drives, but among the changes from the previous generation are door handles ...
The Kite Loft's 47th annual Sunfest Kite Festival will take place in Ocean City, Maryland, from September 18-21, 2025. The festival will feature a variety of uniquely shaped kites, including dragons, ...
Local birder Clarence Yeung, who lives fewer than 10 minutes from the park, rushed out with his camera after the alert on eBird's rare bird alert system. For Yeung, it was a "lifer"—a term birders use ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback